Authors
Christina Downey, MD, is chair of the Government Affairs Committee with the American College of Rheumatology.
Director of Value-Based Clinical Performance & Development at Highmark Health
Advertisement
Advertisement
Trending on AJMC
1
Four Major Idiopathic Pulmonary Fibrosis Advances From 2026
2
Machine Learning Has High Accuracy, Little Prospective Validation in MPNs
3
HHS Draft Policy Eases Enforcement on 6 Compounded Peptides
4
BPC-157 'Wolverine Peptide' Use Rose 33-Fold Despite Scant Evidence
5
